Co-Diagnostics, Inc. (CODX)

Import this data to Google Sheets with:

=jivedata("CODX","financials")

Full statements spill as a table. For one cell: =jivedata("CODX","Revenue") or =jivedata("CODX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Co-Diagnostics, Inc.

CODX • CIK 0001692415

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$6,812.038	$3,915.16	$622.489	$721.386
Cost of Revenue	$4,184.949	$999.124	$222.377	$407.752
Gross Profit	$2,627.089	$2,916.036	$400.112	$313.634
Operating Income (Loss)	$-42,706.234	$-40,081.31	$-50,165.352	$-48,964.828
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-38,110.556	$-37,581.64	$-48,511.914	$-48,676.993
Income Tax Expense (Benefit)	$-2,777.691	$57.368	$-1,615.978	$-1,620.621
Net Income (Loss) Attributable to Parent	$-35,332.865	$-37,639.008	$-46,895.936	$-47,056.372
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	—	—	$-418.443	$-418.443
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-35,479.305	$-37,367.265	$-47,314.379	$-47,190.44
Weighted Average Number of Shares Outstanding, Basic	29,346,599	30,335,350	1,330,200	-27,963,986
Selling and Marketing Expense	$6,860.815	$4,483.339	$2,381.131	$2,049.025
General and Administrative Expense	$14,279.441	$16,157.152	$9,058.283	$7,689.081
Research and Development Expense	$22,962.593	$20,979.589	$19,137.242	$19,666.122
Depreciation, Depletion and Amortization, Nonproduction	$1,230.474	$1,377.266	$1,106.808	$992.234
Asset Impairment Charges	$0	—	$18,882	$18,882
Operating Expenses	$45,333.323	$42,997.346	$50,565.464	$49,278.462
Interest Income, Other	$1,161.913	$1,091.825	$292.932	$291.642
Realized Investment Gains (Losses)	$2,243.059	$870.745	$683.365	$683.365
Gain (Loss) on Disposition of Assets	$-2.578	$8.291	$-82.421	$-82.421
Gain (Loss) on Sale of Investments	$100.703	$-186.067	$-46.301	$-96.615
Nonoperating Income (Expense)	$4,595.678	$2,499.67	$1,653.438	$287.835
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$-146.44	$271.743	$-418.443	$-418.443

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$14,916.878	$2,936.544	$11,884.607	$3,649.632
Marketable Securities, Current	$43,631.51	$26,811.098	$26,811.098	$2,247.638
Property, Plant and Equipment, Net	$3,035.729	$2,761.28	$2,272.098	$1,975.111
Accounts Receivable, after Allowance for Credit Loss, Current	$303.926	$132.57	$190.375	$52.059
Operating Lease, Right-of-Use Asset	$2,966.774	$2,114.876	$1,207.453	$1,769.011
Inventory, Net	$1,664.725	$1,072.724	$992.397	$841.669
Intangible Assets, Net (Excluding Goodwill)	$26,403.667	$26,101	$7,219	$7,219
Income Taxes Receivable, Current	—	—	$44.559	$0.425
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	—	$731.065	$350.569	$435.051
Prepaid Expense and Other Assets, Current	$1,597.114	$1,338.762	$581.527	$648.673
Assets	$95,320.66	$63,999.919	$24,742.585	$16,590.631
Assets, Current	$62,141.108	$32,291.698	$13,693.465	$5,192.458
Liabilities	$9,307.045	$9,688.001	$4,113.921	$3,878.282
Accounts Payable, Current	$1,482.109	$3,294.254	$1,878.225	$1,078.38
Accrued Liabilities, Current	$2,172.959	$2,562.169	$865.301	$899.183
Operating Lease, Liability, Current	$838.387	$915.619	$662.258	$784.261
AssetAcquisitionContingentConsiderationLiabilityCurrent	$891.666	$502.819	$119.036	$72.927
Contract with Customer, Liability, Current	$362.449	$40.857	$14.8	$28.644
Liabilities, Current	$5,747.57	$7,315.718	$3,539.62	$2,863.395
Operating Lease, Liability, Noncurrent	$2,152.18	$1,236.56	$574.301	$1,014.887
AssetAcquisitionContingentConsiderationLiabilityNoncurrent	$748.109	$422.08	$422.08	$98.557
Liabilities, Noncurrent	$3,559.475	$2,372.283	$574.301	$1,014.887
Common Stock, Value, Issued	$36.108	$37.902	$67.7	$70.484
Treasury Stock, Value	$15,575.795	$15,575.795	$15,575.795	$15,575.795
Additional Paid in Capital	$96,808.436	$102,472.21	$116,510.298	$124,015.023
Accumulated Other Comprehensive Income (Loss), Net of Tax	$146.7	$418.443	$418.443	$94.888
Retained Earnings (Accumulated Deficit)	$4,598.166	$-33,040.842	$-80,373.539	$-95,797.363
Stockholders' Equity Attributable to Parent	$86,013.615	$54,311.918	$20,628.664	$12,712.349
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	100,000,000	100,000,000	100,000,000	100,000,000
Common Stock, Shares, Issued	36,108,346	37,902,222	2,256,654	5,040,580
Common Stock, Shares, Outstanding	31,259,668	33,053,544	2,095,031	4,878,957
Treasury Stock, Common, Shares	4,848,678	4,848,678	161,623	161,623

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-35,332.865	$-37,639.008	$-46,895.936	$-47,056.372
Net Cash Provided by (Used in) Operating Activities	$-22,081.865	$-29,155.045	$-29,136.927	$-27,103.203
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-8,056.925	$-11,980.334	$8,948.063	$-7,465.549
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$14,916.878	$2,936.544	$11,884.607	$18,212.557
Depreciation, Depletion and Amortization, Nonproduction	$1,230.474	$1,377.266	$1,106.808	$992.234
Payments to Acquire Property, Plant, and Equipment	$1,365.306	$748.352	$700.047	$367.372
Asset Impairment Charges	$0	—	$18,882	$18,882
Proceeds from Sale and Maturity of Marketable Securities	$127,251.619	$58,765.487	$33,666.959	$33,666.959
Share-based Payment Arrangement, Noncash Expense	$8,336.855	$5,434.904	$2,248.053	$1,225.426
Payments to Acquire Marketable Securities	$110,497.444	$40,802.588	$6,590.939	$6,590.939
Payments to Acquire Interest in Joint Venture	—	$143.75	$102.566	$102.566
Net Cash Provided by (Used in) Investing Activities	$15,388.869	$17,070.797	$26,273.407	$1,535.174
Realized Investment Gains (Losses)	$2,243.059	$870.745	$683.365	$683.365
Gain (Loss) on Sale of Investments	$100.703	$-186.067	$-46.301	$-96.615
Gain (Loss) on Disposition of Assets	$-2.578	$8.291	$-82.421	$-82.421
Accounts Receivable, Allowance for Credit Loss, Recovery	—	—	$26.006	$26.006
Inventory Write-down	$3,233.281	$326.512	$-50.944	$-14.857
Proceeds from Stock Options Exercised	—	—	$12.5	$12.5
Proceeds from Issuance Initial Public Offering	—	$103.914	$1,810.813	$1,810.813
Net Cash Provided by (Used in) Financing Activities	$-1,363.929	$103.914	$11,811.583	$18,102.48
Income Taxes Paid, Net	$55.975	$55.975	$-858.87	$-858.87
Stock Issued	—	$126.75	$126.75	$126.75
Increase (Decrease) in Accounts Receivable	$-2,536.988	$-186.391	$31.799	$-171.11
Increase (Decrease) in Prepaid Expense	$-1,082.536	$-412.056	$-585.926	$127.096
Increase (Decrease) in Inventories	$-413.14	$-265.489	$-131.271	$-257.815
Increase (Decrease) in Contract with Customer, Liability	$362.449	$-321.592	$-26.057	$-17.213
Increase (Decrease) in Income Taxes Payable	$-522.098	$54.457	$-713.643	$-713.643
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$1,768.326	$2,157.85	$-3,112.897	$-665.76

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("CODX","financials")

Full statements spill as a table. For one cell: =jivedata("CODX","Revenue") or =jivedata("CODX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.